Previous close | 131.40 |
Open | 131.10 |
Bid | 131.20 x 30000 |
Ask | 132.25 x 30000 |
Day's range | 131.05 - 131.55 |
52-week range | 82.54 - 133.35 |
Volume | |
Avg. volume | 194 |
Market cap | 31.974B |
Beta (5Y monthly) | 1.08 |
PE ratio (TTM) | 49.45 |
EPS (TTM) | 2.65 |
Earnings date | 31 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | 1.33 (1.01%) |
Ex-dividend date | 20 Feb 2024 |
1y target est | 125.67 |
Does Xylem (XYL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Xylem Inc. (XYL) continued its streak of surpassing revenue expectations.
Xylem (XYL) benefits from strength in the M&CS segment and the acquisition of Evoqua. Its measures to reward its shareholders are encouraging.